Tumor R2* Is a Prognostic Indicator of Acute Radiotherapeutic Response in Rodent Tumors

Journal of Magnetic Resonance Imaging

Volumn 19, Issue 4, 2004, Pages 482-488

  Rodrigues, Loreta M ^a   Howe, Franklyn A ^a   Griffiths, John R ^a   Robinson, Simon P ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

BOLD MRI; Carbogen; Oxygenation; Radiotherapy; Tumor

Indexed keywords

CARBOGEN; CARBON DIOXIDE; OXYGEN; RADIOSENSITIZING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GRAFT; CANCER RADIOTHERAPY; CONTROLLED STUDY; FEMALE; FIBROSARCOMA; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROLACTINOMA; RADIOSENSITIVITY; RAT; TISSUE OXYGENATION; ANIMAL; C3H MOUSE; CANCER TRANSPLANTATION; IMAGE PROCESSING; METABOLISM; METHODOLOGY; MOUSE; PATHOLOGY; RADIATION DOSE; WISTAR FURTH RAT;

ANIMALS; CARBON DIOXIDE; FEMALE; FIBROSARCOMA; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MICE; MICE, INBRED C3H; NEOPLASM TRANSPLANTATION; OXYGEN; PROGNOSIS; PROLACTINOMA; RADIATION-SENSITIZING AGENTS; RADIOTHERAPY DOSAGE; RATS; RATS, INBRED WF;

EID: 1842485849     PISSN: 10531807     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmri.20024     Document Type: Article

References (49)

1. Horsman MR. Measurement of tumour oxygenation. Int J Radiat Oncol Biol Phys 1998:42:701-704.
2. Raghunand N, Gillies RJ. pH and drug resistance in tumours. Drug Resist Updat 2000;3:39-47.
3. Dachs GU, Chaplin DJ. Microenvironmental control of gene expression: implications for tumour angtogenesis, progression and metastasis. Semin Radiat Oncol 1998;8:208-216.
4. Adams GE. Hypoxia-mediated drugs for radiation and chemotherapy. Cancer 1981;48:696-707.
5. Dische S. Hyperbaric oxygen: the Medical Research Council trials and their clinical significance. Br J Radiol 1979;51:888-894.
6. Rojas A. Radiosensitisation with normobaric oxygen and carbogen. Radiother Oncol 1991;20:65-70.
7. Chaplin DJ, Horsman MR, Aoki DS, Nicotinamide, Fluosol DA and carbogen: a strategy to reoxygenate acutely and chronically hypoxic cells in vivo. Br J Cancer 1991;63:109-113.
8. Kjellen E, Joiner MC, Collier JM, Johns H, Rojas A. A therapeutic benefit from combining normobaric carbogen or oxygen with nicotinamide in fractionated X-ray treatments. Radiother Oncol 1991; 22:81-91.
9. Hoskin PJ, Saunders MI, Phillips H, et al. Carbogen and nicotinamide in the treatment of bladder cancer with radical radiotherapy. Br J Cancer 1997;76:260-263.
10. Kaanders JHAM, Pop LAM, Marres HAM, et al. ARCON: experience in 215 patients with advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 2002;52:769-778.
11. Bernier J, Denekamp J, Rojas A, et al. ARCON: accelerated radiotherapy with carbogen and nicotinamide in non small cell lung cancer: a phase I/II study by the EORTC. Radiother Oncol 1999; 52:149-156.
12. Vaupel P, Schlenger K, Knoop C, Höckel M. Oxygenation of human tumors: evaluation of tissue oxygen distribution in breast cancers by computerized 02 tension measurements. Cancer Res 1991;51: 3316-3322.
13. Hockel M, Schlenger K, Knoop C, Vaupel P. Oxygenation of carcinomas of the uterine cervix: evaluation by computerized 02 tension measurements. Cancer Res 1991;51:6098-6102.
14. Brizel DM, Rosner GL, Harrelson J, Prosnitz LR, Dewhirst MW. Pretreatment oxygenation profiles of human soft tissue sarcomas. Int J Radiat Oncol Biol Phys 1994;30:635-642.
15. Brizel DM, Scully SP, Harrelson J, et al. Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. Cancer Res 1996;56:941-943.
16. Brizel DM, Sibley GS, Prosnitz LR, Scher RL, Dewhirst MW. Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 1997;38:285-289.
17. Hockel M, Schlenger K, Aral B, Mitze M, Schäffer U, Vaupel P. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res 1996;56:4509-4515.
18. Nordsmark M, Overgaard M, Overgaard J. Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck. Radiother Oncol 1996;41:31-39.
19. Fyles AW, Milosevic M, Wong R, et al. Oxygenation predicts radiation response and survival in patients with cervix cancer. Radiother Oncol 1998;48:149-156.
20. Dardzinski BJ, Sotak CH. Rapid tissue oxygen tension mapping using 19F inversion-recovery echo-planar imaging of perfluoro-15-crown-5-ether. Magn Reson Med 1994;32:88-97.
21. 19F MRI of perfluorocarbons. Curr Sci 1999;76:753-762.
22. Hunjan S, Zhao D, Constantinescu A, Hahn EW, Antich PP. Mason RP. Tumor oximetry: demonstration of an enhanced dynamic mapping procedure using fluorine-19 echo planar magnetic resonance imaging in the Dunning prostate R3327-AT1 rat tumor. Int J Radiat Oncol Biol Phys 2001;49:1097-1108.
23. Ogawa S, Menon RS, Tank DW, et al. Functional brain mapping by blood oxygenation level-dependent contrast magnetic resonance imaging. Biophys J 1993;64:803-812.
24. Dunn JF, Zaim-Wadghiri Y, Pogue BW, Kida I. BOLD MRI versus NIR spectrophotometry. Will the best technique come forward? Adv Exp Med Biol 1998;454:103-113.
25. Punwani S, Ordidge RJ, Cooper CE, Amess P, Clemence M. MRI measurements of cerebral deoxyhaemoglobin concentration [dHb]-correlation with near infrared spectroscopy (NIRS). NMR Biomed 1998;11:281-289.
26. 2* and arterial blood gases. Magn Reson Imag 2001;19:161-166.
27. Robinson SP, Rijken PFJW, Howe FA, et al. Tumor vascular architecture and function evaluated by non-invasive susceptibility MRI methods and immunohistochemistry. J Magn Reson Imaging 2003; 17:445-454.
28. Howe FA, Robinson SP, Rodrigues LM, Griffiths JR. Flow and oxygenation dependent (FLOOD) contrast MR imaging to monitor the response of rat tumours to carbogen breathing. Magn Reson Imag 1999;17:1307-1318.
29. Howe FA, Robinson SP, McIntyre DJO, Stubbs M, Griffiths JR. Issues in flow and oxygenation dependent contrast (FLOOD) imaging of tumors. NMR Biomed 2001;14:497-506.
30. Al-Hallaq HA, River JN, Zamora M, Oikawa H, Karczmar GS. Correlation of magnetic resonance and oxygen microelectrode measurements of carbogen-induced changes in tumor oxygenation. Int J Radiat Oncol Biol Phys 1998;41:151-159.
31. Al-Hallaq HA, Zamora M, Fish BL, Farrell A, Moulder JE, Karczmar GS. MRI measurements correctly predict the relative effects of tumor oxygenating agents on hypoxic fraction in rodent BA1112 tumors. Int J Rad Oncol Biol Phys 2000;47:481-488.
32. 2) inside tumors? Magn Reson Med 2002;48:980-986.
33. Dunn JF, O'Hara JA, Zaim-Wadghiri Y, et al. Changes in oxygenation of intracranial tumors with carbogen: a BOLD MRI and EPR oximetry study. J Magn Reson Imaging 2002;16:511-521.
34. Griffiths JR, Taylor NJ, Howe FA, et al. The response of human tumors to carbogen breathing, monitored by gradient-recalled echo magnetic resonance imaging. Int J Radiat Oncol Biol Phys 1997; 39:697-701.
35. Taylor NJ, Baddeley H, Goodchild KA, et al. BOLD MRI of human tumour oxygenation during carbogen breathing. J Magn Reson Imaging 2001;14:156-163.
36. Rijpkema M, Kaanders JHAM, Joosten FBM, van der Kogel AJ, Heerschap A. Effects of breathing a hyperoxic hypercapnic gas mixture on blood oxygenation and vascularity of head and neck tumors as measured by MRI. Int J Radiat Oncol Biol Phys 2002; 53:1185-1191.
37. 2 using a fibre-optic oxygen sensor in rodent tumours and their response to carbogen breathing. In: Proceedings of the 6th Annual Meeting of ISMRM, Sydney, Australia. 1998. p 1665.
38. Robinson SP, Collingridge DR, Rodrigues LM, Howe FA, Chaplin J, Griffiths JR. Tumour response to hypercapnia and hyperoxia monitored by FLOOD magnetic resonance imaging. NMR Biomed 1999;12:98-106.
39. Prysor-Jones RA, Jenkins JS. Effect of bromocriptine on DNA synthesis, growth and hormone secretion of spontaneous pituitary tumours in the rat. J Endocrinol 1981;88:463-469.
40. Twentyman PR, Brown JM, Gray JW, Franko AJ, Scoles MA, Kallman RF. A new mouse tumor model system (RIF-1) for comparison of end-point studies. J Natl Cancer Inst 1980;64:595-604.
41. Menke H, Vaupel P. Effect of injectable or inhalational anesthetics and of neuroleptic, neuroleptanalgesic, and sedative agents on tumor blood flow. Radiat Res 1988;114:64-76.
42. 31p NMR spectroscopic study of bioenergetic changes in radiation-induced fibrosarcoma-1 after radiation therapy. NMR Biomed 1989;2:165-171.
43. Tozer GM, Bhujwalla ZM, Griffiths JR, Maxwell RJ. Phosphorus-31 magnetic resonance spectroscopy and blood perfusion of the RIF-1 tumor following x-irradiation. Int J Radiat Oncol Biol Phys 1989; 16:155-164.
44. 2 measurements by electron paramagnetic resonance oximetry. Radiat Res 1998;150:549-556.
45. Zhao D, Constantinescu A, Chang KC, Gall K, Hahn EW, Mason RP. Measurement of tumor oxygen dynamics correctly predicts beneficial adjuvant intervention for radiotherapy in Dunning prostate R3327-HI tumors. In: Proceedings of the 10th Annual Meeting of ISMRM, Honolulu. Hawaii, 2002. p 2149.
46. Goda F, Bacic G, O'Hara JA, Gallez B, Swartz HM, Dunn JF. The relationship between partial pressure of oxygen and perfusion in two murine tumors after X-ray irradiation: a combined gadopentetate dimeglumine dynamic magnetic resonance imaging and in vivo electron paramagnetic resonance oximetry study. Cancer Res 1996;56:3344-3349.
47. Cooper RA, Carrington BM, Loncaster JA, et al. Tumour oxygenation levels correlate with dynamic contrast-enhanced magnetic resonance imaging parameters in carcinoma of the cervix. Radiother Oncol 2000;57:53-59.
48. Lyng H, Vorren AO, Sundfør K, et al. Assessment of tumour oxygenation in human cervical carcinoma by use of dynamic Gd-DTPA-enhanced MR imaging. J Magn Reson Imaging 2001;14:750-756.
49. 2* maps obtained from BOLD images. In: Proceedings of the 10th Annual Meeting of ISMRM, Honolulu, Hawaii. 2002. p. 2065.